학술논문

Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
Document Type
Short Communication
Source
In JTO Clinical and Research Reports August 2022 3(8)
Subject
Language
ISSN
2666-3643